My factory was founded in 1996 in Rui'an, China
Our company is recognized as a major pharmaceutical equipment manufacturer and a distributor of packaging materials and pharmaceutical chemicals .
Our main products includes:Fluid Bed Dryer,Spray Drying Machine,Powder Mixing Machine,Granulating Machine,Capsule filling machine,Blister Packing Machine,Cartoning machine,Tablet Pressing Machine,Bottling Machinery,Liquid Production Line,All kinds of lamination films for pharma packaging,Several kinds of APIs
Our Faith: Your Best Pharmaceutical Production Solution!
Based on our experienced engineering team, we produce top quality machines, paking materials and APIs and also help customers select the best quality suppliers. Our company is a technology-driven company and focuses on producing high quality machinery.
We employ 15 engineers on machinery design and technology improvement. Each engineer has at least ten years' machining and packaging area experience. We are your extra technical consultant center.
Quality Control: 
Our company owns a quality control department to verify each product at different phases, from the procurement of parts to finished products.
 In order to offer clients the best quality products, we manufacture products in accordance with international standards, such as FDA, GMP and cGMP.
  • We have a technical team that has been in the pharmaceutical industry for more than 20 years as a technical support.

  • Based on client’s convenience, economical cost, saving energy and environmental friendly, we design, manufacture and improve the machines. 

  • Standard one year free warranty includes electrical parts and mechanical parts. 7*24hours hotline with wechat,whatsapp,facebook online service. 

  • Long Experience in
    Pharma Industry

  • Professional Plat 

  • Time After Sales

LEADTOP commitment
  • pre-sales
    Response in time and make a reasonable quotation
    Ensure the best quality and delivery time
    Handle quality problems in time
  • 12


    Eisai Co said Friday thata global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid beta protofibril antibody, in patients with early Alzheimer’s disease has been initiated.
  • 12


    New online research from YouGov into the use of artificial intelligence (AI) in the workplace has revealed that only one in ten office workers surveyed in the health sector .